Matthew L. Sherman, EVP & Chief Medical Officer at ACCELERON PHARMA INC (XLRN), sold 26,000 shares at $34.89 ($903K) on 2016-07-01, disclosed to the SEC on 2016-07-06.
Open-market sale of $903k XLRN by EVP & Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $34.20 | 5,793 | $198K | 21.9% |
| 2 | $34.89 | 20,207 | $705K | 78.1% |
| Total | $34.74 avg | 26,000 | $903K | 100% |
| Filing → |
| DCPH | SELL | 2023-12-14 | $43K | — | Filing → |
| DCPH | SELL | 2023-10-31 | $28K | — | Filing → |
| DCPH | SELL | 2023-10-04 | $37K | — | Filing → |